Registered entities
Amylyx Pharmaceuticals Inc.
Reg. No. 464600503United States
AMYLYX PHARMACEUTICALS, INC.
Reg. No. 6477653United States
Amylyx Pharmaceuticals, Inc.
Reg. No. 5463474United States
AMYLYX PHARMACEUTICALS, INC.
Reg. No. 1658551United States
AMYLYX PHARMACEUTICALS UK LIMITED
Reg. No. 14766294United Kingdom
Social engagement
Social engagement: 75.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
18 investors on record; lead investors include Morningside, Viking Global Investors; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 50% |
| Private equity | 3 | 17% |
| Other / undisclosed | 6 | 33% |
Hiring activity
Hires periodically
9 roles tracked across 3 of the last 12 months
23 Jan 2026 · Regional Scientific Director, Central · Dallas
3 Dec 2025 · Director, Biostatistics · Cambridge
21 Nov 2025 · Vice President, Biostatistics · Cambridge
6 Nov 2025 · Director, Employee Relations and HR Operations Partner · Cambridge
6 Nov 2025 · Senior Director, Field Medical Affairs · Louisville
Based on job postings tracked across public sources.
Recent activity
24 Jun 2026
Event
European Network to Cure ALS (ENCALS) 2026 Meeting
5 Jun 2026
Event
World Orphan Drug Congress USA 2026